Monte Rosa Therapeutics, Inc. |
10%+ Owner |
Common Stock |
7.69M |
$146M |
$19.00 |
Jun 28, 2021 |
Indirect |
Trevi Therapeutics, Inc. |
10%+ Owner |
Pre-Funded Warrants |
3M |
$5.7M |
$1.90 |
Apr 11, 2022 |
Indirect |
Trevi Therapeutics, Inc. |
10%+ Owner |
Common Stock |
949K |
$1.92M |
$2.02 |
Apr 11, 2022 |
Indirect |
Metacrine, Inc. |
10%+ Owner |
Common Stock |
2.56M |
$1.2M |
$0.47 |
Dec 22, 2021 |
Indirect |
Robinhood Markets, Inc. |
Director |
Class A Common Stock |
270 |
$3.32K |
$12.28 |
May 2, 2022 |
Indirect |
Eargo, Inc. |
10%+ Owner |
Common Stock |
821 |
$2.13K |
$2.59 |
May 24, 2021 |
Indirect |
IonQ, Inc. |
10%+ Owner |
Common Stock |
70 |
$925 |
$13.21 |
Nov 16, 2022 |
Indirect |
Arcellx, Inc. |
10%+ Owner |
Common Stock |
12 |
$663 |
$55.27 |
Dec 20, 2022 |
Indirect |
AVEO PHARMACEUTICALS, INC. |
10%+ Owner |
Common Stock |
24 |
$360 |
$15.00 |
Oct 19, 2022 |
Indirect |
Desktop Metal, Inc. |
10%+ Owner |
Class A Common Stock |
54 |
$39.60 |
$0.73 |
Jun 8, 2021 |
Indirect |
Trevi Therapeutics, Inc. |
10%+ Owner |
3.5-Year Common Stock Warrant |
1.85M |
|
|
Oct 18, 2021 |
Indirect |
Trevi Therapeutics, Inc. |
10%+ Owner |
7-Year Common Stock Warrant |
1.85M |
|
|
Oct 18, 2021 |
Indirect |
Bright Health Group Inc. |
10%+ Owner |
Series A Convertible Perpetual Preferred Stock |
125K |
|
|
Jan 3, 2022 |
Indirect |
Bright Health Group Inc. |
10%+ Owner |
Series B Convertible Perpetual Preferred Stock |
100K |
|
|
Oct 17, 2022 |
Indirect |
Akouos, Inc. |
10%+ Owner |
Common Stock |
0 |
|
$12.50 |
Nov 30, 2022 |
Indirect |
GENOCEA BIOSCIENCES, INC. |
10%+ Owner |
Common Stock |
0 |
|
$1.25 |
May 25, 2022 |
Indirect |
Monte Rosa Therapeutics, Inc. |
10%+ Owner |
Series A-2 convertible preferred stock |
0 |
|
|
Jun 28, 2021 |
Indirect |
Monte Rosa Therapeutics, Inc. |
10%+ Owner |
Series B convertible preferred stock |
0 |
|
$2.00 |
Jun 28, 2021 |
Indirect |
Monte Rosa Therapeutics, Inc. |
10%+ Owner |
Series C convertible preferred Stock |
0 |
|
$2.96 |
Jun 28, 2021 |
Indirect |
Robinhood Markets, Inc. |
Director |
Common Stock |
0 |
|
$34.32 |
Aug 2, 2021 |
Indirect |
Robinhood Markets, Inc. |
Director |
Series B Redeemable Convertible Preferred Stock |
0 |
|
|
Aug 2, 2021 |
Indirect |
Robinhood Markets, Inc. |
Director |
Series C Redeemable Convertible Preferred Stock |
0 |
|
|
Aug 2, 2021 |
Indirect |
Robinhood Markets, Inc. |
Director |
Series D Redeemable Convertible Preferred Stock |
0 |
|
|
Aug 2, 2021 |
Indirect |
Robinhood Markets, Inc. |
Director |
Series E Redeemable Convertible Preferred Stock |
0 |
|
|
Aug 2, 2021 |
Indirect |
Robinhood Markets, Inc. |
Director |
Series F Redeemable Convertible Preferred Stock |
0 |
|
|
Aug 2, 2021 |
Indirect |
Robinhood Markets, Inc. |
Director |
Tranche I Convertible Promissory Note |
0 |
|
|
Aug 2, 2021 |
Indirect |